Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood Neutrophils.
Bleecker ER, Panettieri RA Jr, Lugogo NL, Corren J, Daizadeh N, Jacob-Nara JA, Deniz Y, Rowe PJ, Khodzhayev A, Soler X, Ferro TJ, Hansen CN. Bleecker ER, et al. Among authors: lugogo nl. J Immunol Res. 2023 Oct 19;2023:9943584. doi: 10.1155/2023/9943584. eCollection 2023. J Immunol Res. 2023. PMID: 37901346 Free PMC article. Clinical Trial.
Are We Ready for Asthma Remission as a Clinical Outcome?
Lugogo NL, Mohan A, Akuthota P, Couillard S, Rhoads S, Wechsler ME. Lugogo NL, et al. Chest. 2023 Oct;164(4):831-834. doi: 10.1016/j.chest.2023.04.028. Chest. 2023. PMID: 37805244 No abstract available.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Epidemiology of asthma.
Lugogo NL, Kraft M. Lugogo NL, et al. Clin Chest Med. 2006 Mar;27(1):1-15, v. doi: 10.1016/j.ccm.2005.10.006. Clin Chest Med. 2006. PMID: 16543048
S-nitrosoglutathione reductase: an important regulator in human asthma.
Que LG, Yang Z, Stamler JS, Lugogo NL, Kraft M. Que LG, et al. Among authors: lugogo nl. Am J Respir Crit Care Med. 2009 Aug 1;180(3):226-31. doi: 10.1164/rccm.200901-0158OC. Epub 2009 Apr 24. Am J Respir Crit Care Med. 2009. PMID: 19395503 Free PMC article.
Does obesity produce a distinct asthma phenotype?
Lugogo NL, Kraft M, Dixon AE. Lugogo NL, et al. J Appl Physiol (1985). 2010 Mar;108(3):729-34. doi: 10.1152/japplphysiol.00845.2009. Epub 2009 Oct 29. J Appl Physiol (1985). 2010. PMID: 19875708 Free PMC article. Review.
Airway fibroblasts in asthma manifest an invasive phenotype.
Ingram JL, Huggins MJ, Church TD, Li Y, Francisco DC, Degan S, Firszt R, Beaver DM, Lugogo NL, Wang Y, Sunday ME, Noble PW, Kraft M. Ingram JL, et al. Among authors: lugogo nl. Am J Respir Crit Care Med. 2011 Jun 15;183(12):1625-32. doi: 10.1164/rccm.201009-1452OC. Epub 2011 Mar 25. Am J Respir Crit Care Med. 2011. PMID: 21471104 Free PMC article.
Surfactant protein A is defective in abrogating inflammation in asthma.
Wang Y, Voelker DR, Lugogo NL, Wang G, Floros J, Ingram JL, Chu HW, Church TD, Kandasamy P, Fertel D, Wright JR, Kraft M. Wang Y, et al. Among authors: lugogo nl. Am J Physiol Lung Cell Mol Physiol. 2011 Oct;301(4):L598-606. doi: 10.1152/ajplung.00381.2010. Epub 2011 Jul 22. Am J Physiol Lung Cell Mol Physiol. 2011. PMID: 21784968 Free PMC article.
121 results